摘要
目的比较不同药物治疗方案治疗2型糖尿病的经济效果,以利糖尿病患者用药更安全、经济、有效。方法将259例患者随机分为3组,运用药物经济学成本-效果分析方法,比较格列吡嗪控释片联合盐酸二甲双胍片(A组)、阿卡波糖口服(B组)、注射胰岛素类似物诺和锐30(C组)3种方案治疗糖尿病的疗效、直接医疗费用和间接费用,并以最小成本分析法进行药物经济学评价。结果 A组、B组、C组总有效率分别为51.16%,62.07%,88.37%,成本-效果比分别为13.85,16.76,12.20。结论从成本-效果分析看,C组为最佳治疗方案。
Objective To compare the economic effects of different pharmacotherapies in treating type 2 diabetes for using medication safer,more economic and more effective.Methods 259 patients were randomly divided into 3 groups.The curative effects,direct and indirect medical costs were compared with the pharmacoeconomic cost-effectiveness analysismethod and the pharmacoeconomic evaluation was performed by cost-minimization analysis method among the three groups.Results The total effective rate in group A,B and C was 51.16%,62.07%and 88.37%respectively.The cost-effectiveness ratio was 13.85 in group A,16.76 in group B and 12.22 in group C respectively.Conclusion Based on the cost-effectiveness analysis,group C is superior to other schemes,which is the optimal treatment scheme for type 2 diabetes.
出处
《中国药业》
CAS
2011年第2期60-61,共2页
China Pharmaceuticals
